Sign in

CIK 0001672619 · Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811523849
Phone
650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,230,845
in 7 filings, $1.6M under 10b5-1 plans

Net −$2,230,845. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hohl Benjamin −$887K CHIEF FINANCIAL OFFICER sold 32% of stake
  2. Collins Helen Louise −$737K CHIEF MEDICAL OFFICER sold 38% of stake
  3. Garland J. Scott −$607K Director sold 100% of stake

Reading 37 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-12-13 New Enterprise Associates 14, L.P. 10% owner Sale −17,501 $2.83 $50K 3,982,161
2021-12-10 New Enterprise Associates 14, L.P. 10% owner Sale −8,667 $2.83 $25K 3,999,662
2021-12-09 New Enterprise Associates 14, L.P. 10% owner Sale −5,666 $2.95 $17K 4,008,329
2021-07-16 Chin Mark Director Purchase +1,333,333 $6.00 $8.0M 2,344,072

Page 37 of 37 · 724 trades